A reduction of tumor necrosis factor-α in paw exudate of lipopolysaccharide treated rats by nimesulide

被引:8
作者
Azab, AN [1 ]
Kaplanski, J [1 ]
机构
[1] Ben Gurion Univ Negev, Dept Clin Pharmacol, IL-84105 Beer Sheva, Israel
关键词
nimesulide; rat; paw; LPS; TNF-alpha;
D O I
10.1016/S0024-3205(01)00960-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
TNF-alpha is considered to play a pivotal role in many inflammatory and illness states. In our previous study we found that nimesulide, a COX-2 selective inhibitor, prevents the lipopolysaccharide-induced elevation in plasma TNF-alpha in rats. The present study was undertaken to elucidate the effect of nimesulide on TNF-alpha levels in the paw exudate of rats pretreated with lipopolysaccharide (LPS). Rats were injected (subplantar) with LPS (100 mug/paw) in the right hind, which resulted in a prominent increase in paw exudate TNF-alpha levels, peaked at one hour post injection. In rats pretreated with nimesulide (30mg/kg, ip), the elevation in TNF-alpha in the paw exudate was significantly reduced, as compared to the LPS treated group. These results further stress the multiple antiinflammatory effects of nimesulide. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1667 / 1675
页数:9
相关论文
共 24 条
[1]
Nimesulide prevents lipopolysaccharide-induced elevation in plasma tumor necrosis factor-α in rats [J].
Azab, A ;
Fraifeld, V ;
Kaplanski, J .
LIFE SCIENCES, 1998, 63 (23) :PL323-PL327
[2]
The tumor necrosis factor ligand and receptor families [J].
Bazzoni, F ;
Beutler, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1717-1725
[3]
The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis [J].
Camussi, G ;
Lupia, E .
DRUGS, 1998, 55 (05) :613-620
[4]
CHEN YL, 1994, EUR J PHARMACOL, V271, P319
[5]
NIMESULIDE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY [J].
DAVIS, R ;
BROGDEN, RN .
DRUGS, 1994, 48 (03) :431-454
[6]
Safety and efficacy of a soluble P75 tumor necrosis factor receptor (enbrel, etanercept) in patients with advanced heart failure [J].
Deswal, A ;
Bozkurt, B ;
Seta, Y ;
Parilti-Eiswirth, S ;
Hayes, FA ;
Blosch, C ;
Mann, DL .
CIRCULATION, 1999, 99 (25) :3224-3226
[7]
Role of cytokines in rheumatoid arthritis [J].
Feldmann, M ;
Brennan, FM ;
Maini, RN .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :397-440
[8]
FU JY, 1990, J BIOL CHEM, V265, P16737
[9]
Cyclo-oxygenase isozymes in mucosal ulcerogenic and functional responses following barrier disruption in rat stomachs [J].
Hirata, T ;
Ukawa, H ;
Yamakuni, H ;
Kato, S ;
Takeuchi, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (03) :447-454
[10]
Insel PA., 1996, Goodman and Gilman's The Pharmacological Basis of Therapeutics, P617